Hyperthyroidism six years post-BMT for acute myeloblastic leukemia in a patient on long-term lithium therapy for bipolar affective disorder

Leuk Lymphoma. 2004 Apr;45(4):807-9. doi: 10.1080/10428190310001617286.

Abstract

Lithium is commonly used to treat bipolar affective disorder. It is well known to adversely affect thyroid function, most commonly causing hypothyroidism. Hyperthyroidism is a rare complication. Similarly, total body irradiation (TBI) associated with BMT is well known to affect thyroid function frequently causing hypothyroidism. Hyperthyroidism secondary to TBI is unusual. To have both a history of chronic lithium therapy and TBI with a BMT in patient presenting with hyperthyroidism is an extremely atypical situation. We describe a 39-year-old male who presented with primary hyperthyroidism after 18 years of lithium use for bipolar affective disorder and 6 years post-BMT for AML-M4.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Bipolar Disorder / complications*
  • Bipolar Disorder / drug therapy
  • Bone Marrow Transplantation / adverse effects*
  • Bone Marrow Transplantation / methods
  • Humans
  • Hyperthyroidism / etiology*
  • Leukemia, Myelomonocytic, Acute / complications*
  • Leukemia, Myelomonocytic, Acute / therapy
  • Lithium / adverse effects*
  • Lithium / therapeutic use
  • Male
  • Thyrotropin / blood
  • Whole-Body Irradiation / adverse effects

Substances

  • Thyrotropin
  • Lithium